These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 28633041)
1. Study of platelet activation, hypercoagulable state, and the association with pulmonary hypertension in children with β-thalassemia. Fayed MA; Abdel-Hady HE; Hafez MM; Salama OS; Al-Tonbary YA Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):65-74. PubMed ID: 28633041 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058 [TBL] [Abstract][Full Text] [Related]
3. Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status. Natesirinilkul R; Charoenkwan P; Nawarawong W; Boonsri S; Tantivate P; Wongjaikum S; Manowong S; Sanguansermsri T Thromb Res; 2016 Apr; 140():125-131. PubMed ID: 26971311 [TBL] [Abstract][Full Text] [Related]
4. Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent β-thalassemia/HbE patients with pulmonary arterial hypertension. Manakeng K; Prasertphol P; Phongpao K; Chuncharunee S; Tanyong D; Worawichawong S; Svasti S; Chaichompoo P Ann Hematol; 2019 Feb; 98(2):281-288. PubMed ID: 30334069 [TBL] [Abstract][Full Text] [Related]
5. Platelet aggregation and activation in thalassemia major patients in Indonesia. Setiabudy R; Wahidiyat PA; Setiawan L Clin Appl Thromb Hemost; 2008 Jul; 14(3):346-51. PubMed ID: 18160592 [TBL] [Abstract][Full Text] [Related]
6. Tricuspid regurgitation in patients with beta-thalassemia major. Wu KH; Chang JS; Su BH; Peng CT Ann Hematol; 2004 Dec; 83(12):779-83. PubMed ID: 15449031 [TBL] [Abstract][Full Text] [Related]
7. Hypercoagulable state in five thalassemia intermedia patients. Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195 [TBL] [Abstract][Full Text] [Related]
8. A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients. Petiwathayakorn T; Paradee N; Hantrakool S; Jarujareet U; Intharah T; Srichairatanakool S; Koonyosying P ACS Appl Bio Mater; 2024 Jul; 7(7):4710-4724. PubMed ID: 38920024 [TBL] [Abstract][Full Text] [Related]
9. Thromboelastometry profile in children with beta-thalassemia. Turhan AB; Bör Ö; Akay OM; Akgün NA Int J Hematol; 2014 Apr; 99(4):407-12. PubMed ID: 24609765 [TBL] [Abstract][Full Text] [Related]
10. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension. Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292 [TBL] [Abstract][Full Text] [Related]
11. Platelet proteome reveals specific proteins associated with platelet activation and the hypercoagulable state in β-thalassmia/HbE patients. Chanpeng P; Svasti S; Paiboonsukwong K; Smith DR; Leecharoenkiat K Sci Rep; 2019 Apr; 9(1):6059. PubMed ID: 30988349 [TBL] [Abstract][Full Text] [Related]
12. Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker. Sherief LM; Dawood O; Ali A; Sherbiny HS; Kamal NM; Elshanshory M; Alazez OA; Alhady MA; Nour M; Mokhtar WA BMC Pediatr; 2017 Mar; 17(1):69. PubMed ID: 28279156 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and pulmonary hypertension in children with beta thalassemia major. Alkholy UM; Mohamed SA; Elhady M; Attar SE; Abdalmonem N; Zaki A J Pediatr (Rio J); 2019; 95(5):593-599. PubMed ID: 29859904 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness. Tantawy AA; Adly AA; Ismail EA; Habeeb NM Eur J Haematol; 2013 Jun; 90(6):508-18. PubMed ID: 23506251 [TBL] [Abstract][Full Text] [Related]
15. Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia. Chhikara A; Sharma S; Chandra J; Nangia A Indian J Pediatr; 2017 Jan; 84(1):25-30. PubMed ID: 27487812 [TBL] [Abstract][Full Text] [Related]
16. A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. Eldor A; Maclouf J; Lellouche F; Ben-Yashar V; Barenholz Y; Durst R; Hy-Am E; Goldfarb A; Rachmilewitz E Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():92-5. PubMed ID: 7886616 [TBL] [Abstract][Full Text] [Related]
17. Protein C levels in beta-thalassemia major patients in the east Nile delta of Egypt. Hassan TH; Elbehedy RM; Youssef DM; Amr GE Hematol Oncol Stem Cell Ther; 2010; 3(2):60-5. PubMed ID: 20543538 [TBL] [Abstract][Full Text] [Related]
18. Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin. Huang Y; Long Y; Deng D; Liu Z; Liang H; Sun N; Xu Y; Lai Y; Cheng P Thromb Res; 2018 Dec; 172():61-66. PubMed ID: 30384036 [TBL] [Abstract][Full Text] [Related]
19. Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients. Zahedpanah M; Azarkeivan A; Aghaieepour M; Nikogoftar M; Ahmadinegad M; Hajibeigi B; Tabatabaiee MR; Maghsudlu M Hematology; 2014 Dec; 19(8):472-6. PubMed ID: 24620948 [TBL] [Abstract][Full Text] [Related]